Adverse Cardiovascular Complications following prescription of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity-score matched Cohort Study with competing risk analysis.

Jiandong ZhouSharen LeeIshan LakhaniLei YangTong LiuYuhui ZhangYunlong XiaWing Tak WongKelvin King Hei BaoIan Chi Kei WongGary TseQingpeng Zhang

Published in: Cardio-oncology (London, England) (2022)

Compared with PD-1 treatment, PD-L1 treatment was significantly associated with lower risk of new onset cardiac complications and all-cause mortality both before and after propensity score matching.

Keyphrases

risk factors
heart failure
emergency department
left ventricular
drug induced